Real-time monitoring of hepatocellular carcinoma radiofrequency ablation by quantitative temperature MRI.

摘要

Early detection of hepatocellular carcinoma (HCC) through surveillance programs allows potentially curative therapies such as resection, liver transplantation, and percutaneous ablation to be applied in 40% of the patients. In nonsurgical candidates, percutaneous treatments are the best therapeutic approach and may improve survival in patients with well-preserved liver function and small tumors who achieve initial complete response. Applying these criteria, 5-year survival rates above 50% have been achieved.